Smith S.S.,University of Wisconsin - Madison |
Rouse L.M.,University of Wisconsin - Milwaukee |
Caskey M.,Menominee Tribal Clinic |
Fossum J.,Menominee Tribal Clinic |
And 3 more authors.
Counseling Psychologist | Year: 2014
This collaborative, community-engaged project developed and tested a Culturally Tailored Treatment (CTT) for American Indian/Alaska Native (AI/AN) smokers in the Menominee tribal community. One hundred three adult AI/AN smokers were randomized to receive either Standard Treatment (ST; n = 53) or CTT (n = 50) for smoking cessation. Both treatment conditions included 12 weeks of varenicline and four individual counseling sessions but differed in terms of cultural tailoring of the counseling. The primary outcome was 7-day, biochemically confirmed point-prevalence abstinence (PPA) at the 6-month end-of-study visit. Both intention-to-treat (ITT) and responder-only analyses were conducted. There were no statistically significant group differences in 7-day PPA. The overall ITT abstinence rate at 6 months was 20%; the responder-only rate was 42%. The current study represents the first randomized smoking cessation clinical trial testing a culturally tailored smoking cessation intervention designed for a specific AI/AN tribal community that combined Food and Drug Administration (FDA)-approved cessation medication (varenicline) and innovative cultural intervention components. © The Author(s) 2014. Source